Martin Christina M, Welge Jeffrey A, Shire Norah J, Shata Mohamed T, Sherman Kenneth E, Blackard Jason T
Department of Internal Medicine, Division of Digestive Diseases, University of Cincinnati College of Medicine, OH 45267, USA.
Cytokine. 2009 Sep;47(3):194-8. doi: 10.1016/j.cyto.2009.06.005. Epub 2009 Jul 21.
Chronic hepatitis B virus infection is characterized by persistent detectable levels of hepatitis B surface antigen (HBsAg) and HBV DNA in the serum. In contrast, HBsAg is not detectable during occult HBV infection, despite the presence of HBV DNA. An altered host immune response could play a role in the development of occult HBV infection; however, potential differences in immune responses among chronic and occult HBV-infected patients have not been evaluated in vivo. In the current study, we evaluated serum levels of regulatory, apoptotic, and fibrotic/anti-fibrotic cytokines/markers as indicators of immune responses in 25 chronic and 12 occult HBV-infected patients. More than half of the patients in both chronic and occult HBV infection groups had IL-2, IL-4, IL-13, and IFN-gamma levels below detectable limits. In contrast, most patients had detectable levels of IL-8, IL-10, IP-10, sFas, sFasL, and TGF-beta1. Of these, only sFas was significantly different between the two groups, with lower levels observed during occult compared to chronic HBV infection (p=0.01). As a surrogate marker of apoptotic inhibition, decreased sFas during occult HBV infection suggests that apoptosis occurs at different rates in occult compared to chronic HBV infection and therefore, may contribute to persistence of occult HBV infection.
慢性乙型肝炎病毒感染的特征是血清中持续可检测到乙型肝炎表面抗原(HBsAg)和HBV DNA水平。相比之下,隐匿性HBV感染期间,尽管存在HBV DNA,但无法检测到HBsAg。宿主免疫反应改变可能在隐匿性HBV感染的发生中起作用;然而,慢性和隐匿性HBV感染患者之间免疫反应的潜在差异尚未在体内进行评估。在本研究中,我们评估了25例慢性HBV感染患者和12例隐匿性HBV感染患者血清中调节性、凋亡性和纤维化/抗纤维化细胞因子/标志物水平,作为免疫反应的指标。慢性和隐匿性HBV感染组中超过一半的患者IL-2、IL-4、IL-13和IFN-γ水平低于可检测限。相比之下,大多数患者的IL-8、IL-10、IP-10、sFas、sFasL和TGF-β1水平可检测到。其中,两组之间只有sFas有显著差异,隐匿性HBV感染期间的水平低于慢性HBV感染(p=0.01)。作为凋亡抑制的替代标志物,隐匿性HBV感染期间sFas降低表明,与慢性HBV感染相比,隐匿性HBV感染中凋亡发生率不同,因此可能导致隐匿性HBV感染的持续存在。